drugset / Trial / NCT01337570

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

NCT01337570

RandomizedParallel-groupDouble-blindPrevention

Summary

This is a double-blind, randomized, placebo-controlled Phase III study to assess the safety and efficacy of a silicone elastomer vaginal ring containing 25mg of dapivirine.

Timeline

Start
2011-07
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject dapivirine Small molecule 25 mg Other